COTP方案治疗非何杰金氏恶性淋巴瘤疗效分析

王建渝; 黄宗干

您当前的位置：

首页 >

文章列表页 >

COTP方案治疗非何杰金氏恶性淋巴瘤疗效分析

更新时间：2024-01-17

- COTP方案治疗非何杰金氏恶性淋巴瘤疗效分析
- Effectiveness of COTP regimen for treatment of Non-Hodgkin lymphoma
- 重庆医科大学学报 2001年第2期页码：191-192
- 作者机构：
  
  重庆医科大学临床学院血液科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R733.1
- 纸质出版日期：2001，
扫描看全文
[1]王建渝,黄宗干.COTP方案治疗非何杰金氏恶性淋巴瘤疗效分析[J].重庆医科大学学报,2001(02):191-192.

Effectiveness of COTP regimen for treatment of Non-Hodgkin lymphoma[J]. Journal of Chongqing Medical University, 2001,(2):191-192.
[1]王建渝,黄宗干.COTP方案治疗非何杰金氏恶性淋巴瘤疗效分析[J].重庆医科大学学报,2001(02):191-192. DOI：

Effectiveness of COTP regimen for treatment of Non-Hodgkin lymphoma[J]. Journal of Chongqing Medical University, 2001,(2):191-192. DOI：

摘要

目的：为了观察吡柔吡星（THP）治疗非何杰金氏淋巴瘤（NHL）的疗效。方法：用THP代替CHOP中的阿霉素（ADM）组成了COTP方案治疗23例NHL。结果：缓解率高达78.2%，而出现毒副反应极小。结论：该方案值得临床推广。

Abstract

Objective: Chemotherapy regimen of CHOP was used in the treatment of Non-Hodgkin lymphoma(NHL). On the basis of it we added THP instead of ADM to improve effectiveness of the treatment on NHL. Method: With the chemotherapy regimen of COTP

we treated 23 patients with NHL during the period from January

1995 to July

2000. Results: For these 23 patients with NHL

the total rate of remission reached 78.2%. The toxicity and side effect of COTP were less severe than those seen in the CHOP. Conclusion: This study suggested that COTP is an effective chemotherapy regimen with less severe toxicity and side effect.

关键词

非何杰金氏淋巴瘤化疗

Keywords

Non-Hodgkin lymphomaPiraubicin

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据